AFL — Aflac Incorporated

Summary of Aflac Incorporated Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Net Earnings: $1.98 per diluted share; adjusted earnings of $1.75 per diluted share, a 6.6% year-over-year increase.
• Aflac Japan: Sales increased by 25.5% driven by new products; however, net earned premiums in yen declined 3.8%.
• Aflac U.S.: Sales rose 2.9% year-over-year; net earned premium increased by 3.5%. Premium persistency remained strong at 79.3%.
• Adjusted Return on Equity (ROE): 12.8%, 16.4% excluding foreign currency remeasurement.
• Capital Management: Returned $1.3 billion to shareholders through dividends and share repurchases; unencumbered liquidity of $3.4 billion.

2. Strategic Updates and Business Highlights

• Aflac Japan's marketing and sales transformation continues to yield strong results, particularly with the launch of new medical and cancer insurance products.
• The company is focusing on enhancing distribution channels and maintaining strong persistency rates to mitigate lapses.
• Aflac has entered a reinsurance transaction with Japan Post Insurance, marking a strategic expansion in its reinsurance franchise.
• The U.S. segment is seeing growth in group voluntary products, with a notable 12.4% increase in group business.

3. Forward Guidance and Outlook

• Aflac Japan aims for sales growth in 2026 to exceed JPY 80 billion, up from JPY 74 billion in 2025.
• The company maintains a full-year benefit ratio guidance for the U.S. segment at 42% to 52%.
• Aflac expects continued solid performance in both segments, despite challenges in the underlying earned premium growth.

4. Bad News, Challenges, or Points of Concern

• Aflac Japan's underlying earned premiums have declined by 1.3%, indicating potential headwinds in premium growth despite strong sales.
• The benefit ratio in Japan remains high at 62.9%, with expectations for improvement dependent on favorable claims experience and premium mix.
• The Corporate & Other segment reported breakeven pretax adjusted earnings, down from a $43 million gain last year, attributed to lower investment income and higher costs.
• Concerns about the impact of inflation and rising costs on consumer behavior and agent recruiting were noted, though persistency remains stable.

5. Notable Q&A Insights

• Capital Generation: The external reinsurance deal had a minor impact on capital, with no significant headwinds affecting the Estimated Solvency Ratio (ESR).
• Lapse and Reissue Activity: Changes in lapse behavior, particularly among younger policyholders, may have minor impacts on internal rate of return (IRR) but are expected to stabilize.
• Benefit Ratio Management: The company anticipates improvements in the Japan benefit ratio, aiming for a target range of 60% to 63% as favorable trends in claims are expected to continue.
• Reinsurance Opportunities: Aflac sees potential for growth in the reinsurance market, with plans to selectively target sizable blocks in Japan over time.
• U.S. Market Dynamics: No significant pressure from state regulators on product rates was reported, and the company remains optimistic about maintaining growth in the U.S. despite competitive pressures.

Overall, Aflac's first quarter results reflect a strong start to 2026, with strategic initiatives in both Japan and the U.S. driving sales growth, though challenges in premium growth and benefit ratios remain areas of focus.